A comparison of the acute effects of dextroamphetamine and fenfluramine in depression

Biological Psychiatry

Volumn 20, Issue 10, 1985, Pages 1090-1097

  Ward, Nicholas G ^a   Ang, Jessy ^a   Pavinich, Gary ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; FENFLURAMINE;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG COMPARISON; DRUG THERAPY; HUMAN; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; THERAPY;

ADULT; AGED; CLINICAL TRIALS; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; FEMALE; FENFLURAMINE; HUMAN; MALE; MIDDLE AGE; NOREPINEPHRINE; PSYCHOLOGICAL TESTS; SEROTONIN;

EID: 0022203675     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(85)90007-1     Document Type: Article

References (47)

1. Serotonin depression—a biochemical subgroup within the affective disorders?
2. 5-HIAA in the cerebrospinal fluid
3. An inventory for measuring depression
4. Dexamethasone suppression test and mood response to methylphenidate in primary depression
5. The double-blind in danger: Untoward consequences of informed consent
6. Differential effects of pharmacological agents acting on monoaminergic systems on drug-induced anorexia
7. Fenfluramine and brain serotonin
8. 5-Hydroxytryptamine (5-HT) in the wholeblood of patients with depressive illness
9. Platelet 5-hydroxytryptamine accumulation in depressive illness
10. Behavior therapy and pharmacotherapy for obesity
11. Plasma tryptophan and five other amino acids in depressed and normal subjects
12. Depression and MHPG excretion
13. Total and free plasma tryptophan levels in patients with affective disorders
14. Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: A microspectrofluorimetric demonstration
15. Cortical dopaminergic involvement in cocaine reinforcement
16. A comparison of fenfluramine and amphetamine in man
17. Relationship between anorectic and reinforcing properties of appetite suppressant drugs: Implications for assessment of abuse liability
18. Endorphins may be involved in the behavioral response to dextroamphetamines
19. A rating scale for depression
20. Effects of diethylpropion and d-amphetamine after subcutaneous and oral adminstration
21. Drug preferences in humans
22. Involvement of the central serotonergic system in affective illness
23. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression
24. Pretreatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment
25. Assessment of the abuse potentiality of amphetamines and LSD-like hallucinogens in man and its relationship to basic animal assessment programs
26. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephredine, phenmetrazine, and methylphenidate in man
27. Relationship between plasma ratio of tryptophan to competing amino acids and the response to l-tryptophan treatment in endogenously depressed patients
28. The serotonergic neurotransmitter system in the affective disorders—a preliminary evaluation of the antidepressant and antimanic effects of fenfluramine
29. Fenluramine: A review of its pharmacological properties and therapeutic efficacy in obesity
30. d-amphetamine as a predictor for response to imipramine and amitriptyline
31. 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers
32. Are receptor studies useful for clinical practice?
33. Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine
34. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression
35. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression
36. Psychopharmacology of anorectic drugs in man
37. 5-Hydroxyindoleacetic acid and homovanilic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment
38. 3H-imipramine binding in schizo-affective and depressive disorders
39. Prediction of imipramine antidepressant response by a one-day d-amphetamine trial
40. New evidence for serotonin-deficient depression
41. Central monoamine metabolism in depressions. I. Serotonin and related compounds
42. Depression, suicide and the metabolism of serotonin in the brain
43. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid